Open access · CC-BY
via OpenAlex
Therapeutic potential of ginseng and ginsenosides on muscle wasting disorders: Cachexia, sarcopenia, anorexia, and aging
Chang-Hwan Bae, Subramanian Muthamil, Ji Hyo Lyu, Jong Min Oh, Ung Cheol Shin, Maic Audo Eybi Mayer Sihombing, Thi Quynh Dan Nguyen, Seon-Wook Kim, Jong‐Hoon Kim, Md.M.N. Azim, Jun Hong Park
Journal of Ginseng Research · 2026
Abstract
Muscle wasting disorders mainly arise from appetite loss, chronic diseases, prolonged immobilization, and aging. Chronic diseases such as cancer, stroke, neurological diseases, heart and kidney dysfunction are the primary reasons for muscle mass loss. Muscle atrophy caused by an imbalance between protein synthesis and degradation in myocytes and the severe muscle-wasting conditions include cachexia, sarcopenia, anorexia, and fatigue. Cachexia is characterized by loss of >5% of body weight or a body mass index (BMI) <20 kg/m 2 . Sarcopenia is characterized by age-associated declines in muscle mass, strength, and gait speed, while anorexia refers to weight loss associated with dietary restriction. Recent evidence suggests that the HIF-1 pathway plays an important role in muscle wasting disorders. Given the significant health burden caused by muscle wasting, there is an urgent need to identify novel biomarkers for clinical diagnosis and to develop effective therapeutic strategies. In this context, plant-derived compounds, particularly ginseng and its bioactive constituent, ginsenosides, have recently been explored for their potential in mitigating muscle wasting conditions. This review provides an updated overview of current research on the therapeutic applications of ginseng and ginsenosides in mitigating muscle atrophy-related conditions, including cachexia, sarcopenia, fatigue, anorexia, aging, and obesity.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.jgr.2026.101021
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Bae, C., Muthamil, S., Lyu, J.H., Oh, J.M., Shin, U.C., Sihombing, M.A.E.M., Nguyen, T.Q.D., Kim, S., Kim, J., Azim, M., & Park, J.H. (2026). Therapeutic potential of ginseng and ginsenosides on muscle wasting disorders: Cachexia, sarcopenia, anorexia, and aging. <em>Journal of Ginseng Research</em>. https://doi.org/10.1016/j.jgr.2026.101021
Vancouver
Bae C, Muthamil S, Lyu JH, Oh JM, Shin UC, Sihombing MAEM, et al. Therapeutic potential of ginseng and ginsenosides on muscle wasting disorders: Cachexia, sarcopenia, anorexia, and aging. Journal of Ginseng Research. 2026. doi:10.1016/j.jgr.2026.101021.
BibTeX
@article{changhwan2026Therap,
title = {Therapeutic potential of ginseng and ginsenosides on muscle wasting disorders: Cachexia, sarcopenia, anorexia, and aging},
author = {Chang-Hwan Bae and Subramanian Muthamil and Ji Hyo Lyu and Jong Min Oh and Ung Cheol Shin and Maic Audo Eybi Mayer Sihombing and Thi Quynh Dan Nguyen and Seon-Wook Kim and Jong‐Hoon Kim and Md.M.N. Azim and Jun Hong Park},
journal = {Journal of Ginseng Research},
year = {2026},
doi = {10.1016/j.jgr.2026.101021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Endocrinology 2024
Open access · CC-BY
Type 2 diabetes mellitus related sarcopenia: a type of muscle loss distinct from sarcopenia and disuse muscle atrophy
Internal and Emergency Medicine 2012
Citation only
Muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia?
Clinical Nutrition 2014
Citation only
Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: From sarcopenic obesity to cachexia
Antioxidants 2021
Open access · CC-BY
Mitochondrial Dysfunction Is a Common Denominator Linking Skeletal Muscle Wasting Due to Disease, Aging, and Prolonged Inactivity
Gerontology 2014
Preprint · OA
Sarcopenia, Cachexia and Aging: Diagnosis, Mechanisms and Therapeutic Options - A Mini-Review
Zenodo (CERN European Organization for Nuclear Research) 2026
Preprint · OA